In contrast, anti–S2 IgG3 Ab levels were more substantial following infection, with 21 of 31 of participants having detectable anti–S2 IgG3 Abs (Figure 4D), and vaccination further improved anti–S2 IgG3 Ab levels (Figure 4D). Here, IGHG3 is linked to infection.